The RAF–MEK–ERK and PI3K–AKT signaling pathways are key players in melanoma progression and drug resistance.13,14 Preclinical studies have implicated a fundamental role of the PI3K–AKT signaling pathway in both metastatic spread to the brain and survival and growth of melanoma cells in the brain microenvironment. Here, MAP2K7 is linked to melanoma.